(NASDAQ: CDNA) Caredx's forecast annual revenue growth rate of 8.43% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.25%.
Caredx's revenue in 2026 is $458,089,000.On average, 9 Wall Street analysts forecast CDNA's revenue for 2026 to be $25,840,727,046, with the lowest CDNA revenue forecast at $23,173,310,508, and the highest CDNA revenue forecast at $26,927,145,729. On average, 9 Wall Street analysts forecast CDNA's revenue for 2027 to be $27,468,803,044, with the lowest CDNA revenue forecast at $24,473,391,532, and the highest CDNA revenue forecast at $29,496,267,243.
In 2028, CDNA is forecast to generate $30,327,636,207 in revenue, with the lowest revenue forecast at $27,394,305,763 and the highest revenue forecast at $33,554,299,696.